FC

Fernando Pumares Clemente

European Sales Manager at BioVentrix

Fernando Pumares Clemente has a wealth of experience in the medical device industry. From 2010 to present, they have worked in various roles for four different companies. At FIORPUMA SL in Barcelona, Spain, they served as Principal, creating the consultancy company as a bridge for start up Medical Device companies to establish a clinical and sales presence in the European Market. At BioVentrix from 2013, they were European Sales Manager, developing the European Ischemic Dilated Cardiomyopathy HF Market and introducing Hybrid Cardiology Therapy into the Structural Heart Market Space. From 2010 to 2013, they were European Sales and Marketing Manager at NCONTACT SURGICAL, INC., introducing a Hybrid Cardiology Procedure for the Atrial Fibrillation Market. From 2003 to 2010, they worked at Boston Scientific in various roles, including Director Marketing International, Group Manager International Marketing, and Northern European Sales Manager. In their roles, they were responsible for launching products, opening new markets, creating international forums of physicians, and growing sales.

Fernando Pumares Clemente received a Bachelor of Science in Mechanical Engineering from UC Irvine between 1982 and 1988. Fernando then went on to pursue a Master of Science in Business Administration from the University of California, Berkeley, Haas School of Business between 1997 and 1999.

Location

Barcelona, Spain

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


BioVentrix

BioVentrix is a privately held medical device company headquartered in San Ramon, CA, USA. Their mission is to improve and expand the treatment available for congestive heart failure (CHF) caused by ischemic cardiomyopathy, through the development of less invasive, catheter-based approaches. Their unique system provides a new solution for multidisciplinary heart teams and their patients by its proven clinical improvements.


Industries

Employees

11-50

Links